1. Metformin and alpha lipoic acid ameliorate hypothyroidism and its complications in adult male rats
   Noha M. Khoder et al, 2022, Journal of Diabetes & Metabolic Disorders CrossRef
2. The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
   Che-Hao Tseng et al, 2023, Cells CrossRef
3. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
   Carolyn T Bramante et al, 2023, The Lancet Infectious Diseases CrossRef
4. Mechanisms and effects of metformin on skeletal muscle disorders
   Ren Shang et al, 2023, Frontiers in Neurology CrossRef
5. Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis, and improving mitochondrial quality and quantity control
   Yujie Zhong et al, 2022, Food & Function CrossRef
6. A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity
   Gregory Livshits et al, 2023, Ageing Research Reviews CrossRef
7. Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
   Raphaëlle Corremans et al, 2023, International Journal of Molecular Sciences CrossRef
8. Metformin modulates mitochondrial autophagy in renal tubular epithelial injury induced by high glucose via the Keap1/Nrf2 pathway
   Da Sun et al, 2023, Molecular and Cellular Biochemistry CrossRef
9. The Role and Mechanism of Metformin in Inflammatory Diseases
   Huan Lin et al, 2023, Journal of Inflammation Research CrossRef
10. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
    Soumik Das et al, 2023, Life Sciences CrossRef